Comparison of a Novel Tazarotene 0.045% Lotion to Tazarotene 0.1% Cream: Patient-Reported Outcomes from a Phase 2 Clinical Trial

Main Article Content

Z Draelos
F Cook-Bolden
L Green
E Guenin
G Martin
R Pillai


Tazarotene, Acne


Abstract not available.


1. Zaenglein AL, et al. J Am Acad Dermatol. 2016;74(5):945-973.
2. Tanghetti EA, et al. J Drugs Dermatol. 2019;18(6):542-548.
3. Acne-specific Quality of Life Questionnaire (Acne-QoL) Manual & Interpretation Guide. January 2003. 01-2019-20-05-40)-Study-related%20document.pdf

Most read articles by the same author(s)

1 2 > >>